经阴道三维超声观察胎儿透明隔腔形成与隔发育
本研究回顾性分析2022年1月至2025年11月116例17+0至24+6周结构正常胎儿的经阴道三维超声脑容积,采用多平面重建评估中线结构并测量胼胝体长度与透明隔腔宽度。结果显示透明隔腔内液体在约18–19周逐渐可见,与胼胝体延长密切相关。
要点
- 透明隔腔液体约在18–19周开始可见,此前呈等回声细胞层而非液体腔
- 透明隔腔可见性与胼胝体长度密切相关,胼胝体长度11.25 mm是转变阈值
- 透明隔腔宽度与胼胝体长度独立相关,与孕周无独立相关
核心结论
- 透明隔腔液体在约18–19周逐渐形成并可见,此前存在短暂细胞相,其出现与胼胝体延长密切相关
研究设计与样本
- 回顾性研究,纳入2022年1月至2025年11月116例17+0至24+6周结构正常胎儿
- 使用经阴道三维超声获取胎儿脑容积,多平面重建评估中线结构并测量胼胝体长度与透明隔腔宽度
主要发现
- 透明隔腔液体可见的估计50%概率对应孕周为19.03周(95%CI,18.32–19.75)
- 孕周预测透明隔腔液体可见的AUC为0.967(95%CI,0.931–1.000)
- 胼胝体长度预测透明隔腔液体可见的AUC为0.972(95%CI,0.943–1.000)
- 胼胝体长度11.25 mm是透明隔腔结构可见转变的最佳阈值
- 透明隔腔宽度与胼胝体长度独立相关(β=0.19;P<0.001),与孕周无独立相关
关键数值与推荐
- 透明隔腔液体评分标准:0=未来透明隔腔内无液体可见;1=部分液体充盈;2=完全液体充盈
- 透明隔腔液体50%可见概率对应孕周19.03周(95%CI,18.32–19.75)
- 胼胝体长度11.25 mm为透明隔腔结构可见转变的最佳阈值
临床怎么用
- 孕18–19周前未显示透明隔腔液体可能属正常发育阶段,需结合胼胝体形态评估
- 评估透明隔腔时应同时测量胼胝体长度,二者发育密切相关
局限性
- 本研究为回顾性设计,样本来自单一时间段和结构正常胎儿,未能直接验证透明隔未显示的临床病例
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABSTRACT Objectives To describe the in-vivo development of the fetal cavum septi pellucidi (CSP) using transvaginal ultrasonography (TVS) and to propose a hypothesis underlying non-visualization of the septum pellucidum (NVSP). Methods In this retrospective study, three-dimensional ultrasound volumes of the fetal brain acquired using TVS between 17 + 0 and 24 + 6 weeks' gestation in structurally normal fetuses between January 2022 and November 2025 were analyzed. Multiplanar reconstruction was performed to allow assessment of midline structures. Corpus callosal (CC) length and CSP width were measured. CSP fluid content was scored from 0 to 2 as follows: 0, no fluid visualized within the future CSP; 1, partially fluid-filled CSP; and 2, completely fluid-filled CSP. Among fetuses with a CSP fluid score of 2, we further assessed the presence of echogenic strands within the CSP. Associations between gestational age, CC length and CSP parameters were analyzed using linear regression, logistic regression and receiver-operating-characteristic (ROC)-curve analyses. Inter- and intraobserver reproducibility were assessed. Results A total of 116 fetuses were included. CSP fluid had an estimated 50% probability of being visualized at 19.03 (95% CI, 18.32–19.75) weeks, with both gestational age (area under the ROC curve (AUC), 0.967 (95% CI, 0.931–1.000)) and CC length (AUC, 0.972 (95% CI, 0.943–1.000)) demonstrating excellent predictive performance for CSP fluid visualization. An optimal threshold for transition into a visualizable CSP structure was seen at a CC length of 11.25 mm. CSP width was associated independently with CC length (β = 0.19; P < 0.001), but not with gestational age. Prior to cavitation, the region beneath the CC appeared as a non-fluid layer of intermediate echogenicity, corresponding to the midline glial guidepost apparatus. A triangular CSP configuration was observed in 18.1% of cases with a visible CSP. Reproducibility was excellent, with an intraclass correlation coefficient of 0.980 (95% CI, 0.947–0.993) for CSP width and a weighted Cohen's κ of 0.75 for the ordinal CSP fluid score between observers. Conclusions The fluid-filled CSP forms gradually, becoming visible at approximately 18–19 weeks after a transient cellular phase beneath the developing CC. CSP appearance is closely linked to CC elongation. We propose a hypothesis in which NVSP, in the presence of a normally formed CC, may result from excessive or disorganized resorption of midli
引用
- Ultrasound in Obstetrics and Gynecology:The ‘early CSP’ is not a CSP: 3D transvaginal neurosonographic study of fetal cavum septi pellucidi formation and septal development
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。